Anabolic steroids detected in bodybuilding dietary supplements - A significant risk to public health

Drug Testing and Analysis

Volumn 7, Issue 7, 2015, Pages 609-618

  Abbate, V ^a   Kicman, A T ^b   Evans Brown, M ^c   Mcveigh, J ^d   Cowan, D A ^b   Wilson, C ^e   Coles, S J ^e   Walker, C J ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^d LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Anabolic steroids; Dietary supplements; Hepatotoxicity; Image enhancing drugs; Performance enhancing drugs; X ray crystallography

Indexed keywords

DIETARY SUPPLEMENTS; GAS CHROMATOGRAPHY; HEALTH RISKS; IMAGE ENHANCEMENT; LIPIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUTRITION; VITAMINS;

ACCURATE MASS; ANABOLIC STEROID; FITNESS EQUIPMENTS; GASCHROMATOGRAPHY-MASS SPECTROMETRY; HEPATOTOXICITY; IMAGE ENHANCING; IMAGE-ENHANCING DRUG; PERFORMANCE ENHANCING; PERFORMANCE-ENHANCING DRUG; UNITED KINGDOM;

X RAY CRYSTALLOGRAPHY;

ANABOLIC AGENT; STEROID;

ARTICLE; BODY BUILDING; CHEMICAL ANALYSIS; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; DIET SUPPLEMENTATION; DRUG EXPOSURE; DRUG LEGISLATION; DRUG MISUSE; HEALTH HAZARD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK FACTOR; ULTRAVIOLET SPECTROSCOPY; UNITED KINGDOM; X RAY CRYSTALLOGRAPHY; ADVERSE EFFECTS; ANALYSIS; DIETARY SUPPLEMENT; DOPING; LIQUID CHROMATOGRAPHY; PROCEDURES; PUBLIC HEALTH; TANDEM MASS SPECTROMETRY; TRENDS; WEIGHT LIFTING;

ANABOLIC AGENTS; CHROMATOGRAPHY, LIQUID; CRYSTALLOGRAPHY, X-RAY; DIETARY SUPPLEMENTS; DOPING IN SPORTS; PUBLIC HEALTH; RISK FACTORS; STEROIDS; TANDEM MASS SPECTROMETRY; WEIGHT LIFTING;

EID: 84937704065     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1728     Document Type: Article

References (46)

1. M. Evans-Brown, J. McVeigh, C. Perkins, M.A. Bellis . Human Enhancement Drugs - The Emerging Challenges to Public Health. North West Public Health Observatory, Liverpool, 2012.
2. U.S. Food and Drug Administration. Tainted_Supplements_CDER. Available at: http://www.accessdata.fda.gov/scripts/sda/sdNavigation.cfm?sd=tainted_supplements_cder [6 June 2014].
3. R. Kazlauskas . Designer steroids, in Doping in Sports: Biochemical Principles, Effects and Analysis. Handbook of Experimental Pharmacology, Vol. 195. (Eds: D. Thieme, P. Hemmersbach ), Springer, Berlin, Heidelberg, 2010, pp. 155-185.
4. M. Evans-Brown, A. Kimergård, J. McVeigh, M. Chandler, S.D. Brandt . Is the breast cancer drug tamoxifen being sold as a bodybuilding dietary supplement? doi: 10.1136/bmj.g1476.
5. L.A. King, A.T. Kicman . A brief history of 'new psychoactive substances. Drug Test. Anal. 2011, 3, 401.
6. P. Griffiths, M. Evans-Brown, R. Sedefov . Getting up to speed with the public health and regulatory challenges posed by new psychoactive substances in the information age. Addiction 2013, 108, 1700.
7. European Monitoring Centre for Drugs and Drug Addiction. EMCDDA-Europol 2010 Annual Report on the Implementation of Council Decision 2005/387/JHA. European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 2011.
8. Twitter. @toxicovigilance. Available at: https://twitter.com/toxicovigilance/status/442231055719084032 [14 May 2014].
9. B.J. Venhuis, D. de Kaste . Scientific opinion on the regulatory status of 1, 3-dimethylamylamine (DMAA). Eur. J. Food Res. Rev. 2012, 2, 93.
10. Medicines and Healthcare products Regulatory Agency. MHRA determines that a product containing 1, 3-Dimethylamylamine (DMAA) is a medicinal product. Available at: http://www.mhra.gov.uk/Howweregulate/Medicines/Medicinesregulatorynews/CON180713 [16 June 2014].
11. P.A. Cohen, J.C. Travis, B.J. Venhuis . A methamphetamine analog (N, α-diethyl-phenylethylamine) identified in a mainstream dietary supplement. Drug Test. Anal. 2013, 10.1002/dta.1578
12. J. Lee, B. Venhuis, S. Heo, H. Choi, I. Seol, E. Kim . Identification and quantitation of N, α-diethylphenethylamine in preworkout supplements sold via the Internet. Forensic Toxicol. 2014, 32, 148.
13. S. Assael . Steroid Nation: Juiced Home Run Totals, Anti-Aging Miracles, and a Hercules in Every High School. ESPN, New York, 2007.
14. J.A. Vida . Androgens and Anabolic Agents. Chemistry and Pharmacology. Academic Press, London, 1969.
15. H.J. Ringold, G. Rosenkranz . Steroids. LXXXIII. Synthesis of 2-methyl and 2, 2-dimethyl hormone analogs. J. Org. Chem. 1956, 21, 1333.
16. H.J. Ringold, E. Batres, O. Halpern, E. Necoechea . Steroids. CV.1 2-methyl and 2-hydroxymethylene-androstane derivatives. J. Am. Chem. Soc. 1959, 8, 427.
17. F.A. Kincl, R.I. Dorfman . Anabolic-androgenic potency of various steroids in a castrated rat assay. Steroids 1964, 3, 109.
18. R.E. Counsell, P.D. Klimstra, F.B. Colton . Anabolic agents. Derivatives of 5α-androst-1-ene. J. Org. Chem. 1962, 27, 248.
19. E. Rohrmann, H.A. Shonle . Aminoalkanes as pressor substances. J. Am. Chem. Soc. 1944, 66, 1516.
20. J. Knoll . New psychostimulant agent. Patent WO 88/02254. World Intellectual Property Organization, 1988. Available at: http://worldwide.espacenet.com/publicationDetails/biblio?CC=EP&NR=0284621B1&KC=B1&FT=D [9 June 2014].
21. Subcommittee on Crime and Drugs of the Committee on the Judiciary United States Senate. Body building products and hidden steroids: Enforcement barriers: Hearing before the Subcommittee on Crime and Drugs of the Committee on the Judiciary United States Senate. One Hundred Eleventh Congress, US Government Printing Office: Washington D.C., 2009.
22. Drug Enforcement Administration. Classification of two steroids, prostanozol and methasterone, as Schedule III anabolic steroids under the Controlled Substance Act. Fed. Reg. 2012, 77, 44456.
23. T. Cash, L. Smolak . Body Image: A Handbook of Science, Practice, and Prevention. Guilford Press, New York, 2011.
24. L.D. Johnston, P.M. O'Malley, J.G. Bachman . Monitoring the Future National Survey Results on Drug Use, 1975-2001. Volume I: Secondary School Students. National Institute on Drug Abuse, Bethesda, 2002.
25. J.B. Jones, J.D. Leman . Steroids and steroidases. XI. synthetic approaches to C-17 Bis(2-hydroxyethyl)-amino compounds as potential precursors of 17-Hydroxyandrostane nitrogen mustards. Can. J. Chem. 1971, 49, 2420.
26. M.K. Parr, M. Guetschow, J. Daniels, G. Opfermann, M. Thevis, W. Schänzer . Identification of steroid isoxazole isomers marketed as designer supplement. Steroids 2009, 74, 322.
27. H.L. Holland, E. Riemland . Microbial hydroxylation of steroids. 10. Rearrangement during epoxidation and hydroxylation, and the stepwise nature of these enzymic reactions. Can. J. Chem. 1985, 63, 1121.
28. K. Krohn, I. Vinke, H. Adam . Transition-metal catalyzed oxidations .7. Zirconium-catalyzed oxidation of primary and secondary alcohols with hydroperoxides. J. Org. Chem. 1996, 61, 1467.
29. M. Rosenberger, R. Borer, G. Saucy . Steroid total synthesis. 11. (+)-Estr-4-ene-3, 17-dione from a chiral lactone. J. Org. Chem. 1978, 43, 1550.
30. S.J. Coles, P.A. Gale . Changing and challenging times for service crystallography. Chem. Sci. 2012, 3, 683.
31. N.V. Lukashev, G.V. Latyshev, P.A. Donez, G.A. Skryabin, I.P. Beletskaya . 6-Chloro- and 6-bromo-substituted steroids in the Suzuki-Miyaura cross-coupling reaction. A convenient route to potential aromatase inhibitors. Synthesis, 2006, 3, 533.
32. H. Geyer, M.K. Parr, K. Koehler, U. Mareck, W. Schänzer, M. Thevis . Nutritional supplements cross-contaminated and faked with doping substances. J. Mass Spectrom. 2008, 43, 892.
33. M.H. Sekera, B.D. Ahrens, Y.C. Chang, B. Starcevic, C. Georgakopoulos, D.H. Catlin . Another designer steroid: Discovery, synthesis, and detection of 'madol' in urine. Rapid Commun. Mass Spectrom. 2005, 19, 781.
34. P. Diel, A. Friedel, H. Geyer, M. Kamber, U. Laudenbach-Leschowsky, W. Schänzer, M. Thevis, G. Vollmer, O. Zierau . Characterisation of the pharmacological profile of desoxymethyltestosterone (Madol), a steroid misused for doping. Toxicol. Lett. 2007, 169, 64.
35. Misuse of Drugs Act 1971. Her Majesty's Stationery Office (HMSO), London, 1971. Available at: http://www.legislation.gov.uk/ukpga/1971/38/contents [9 June 2014].
36. The Misuse of Drugs Act 1971 (Modification) Order 1996. Her Majesty's Stationery Office (HMSO), London, 1996. Available at: http://www.legislation.gov.uk/uksi/1996/1300/article/2/made [9 June 2014].
37. The Misuse of Drugs Act 1971 (Amendment) Order 2009. Her Majesty's Stationery Office (HMSO), London, 2009. Available at: http://www.legislation.gov.uk/ukdsi/2009/9780111486610/article/2 [9 June 2014].
38. B. Jasiurkowski, J. Raj, D. Wisinger, R. Carlson, L. Zou, A. Nadir . Cholestatic jaundice and IgA nephropathy induced by OTC muscle building agent superdrol. Am. J. Gastroenterol. 2006, 101, 2659.
39. M.I. Kafrouni, R.A. Anders, S. Verma . Hepatotoxicity associated with dietary supplements containing anabolic steroids. Clin. Gastroenterol. Hepatol. 2007, 5, 809.
40. N.L. Shah, I. Zacharias, U. Khettry, N. Afdhal, F.D. Gordon . Methasteron-associated cholestatic liver injury: Clinicopathologic findings in 5 cases. Clin. Gastroenterol. Hepatol. 2008, 6, 255.
41. V. Singh, M. Rudraraju, E.J. Carey, T.J. Byrne, H.E. Vargas, J.E. Williams, V. Balan, D.D. Douglas, J. Rakela . Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement. J. Clin. Gastroenterol. 2009, 43, 287.
42. J. Nasr, J. Ahmad . Severe cholestasis and renal failure associated with the use of thedesigner steroid Superdrol™ (Methasteron™): A case report and literature review. Dig. Dis. Sci. 2009, 54, 1144.
43. P.V. Krishnan, Z.-Z. Feng, S.C. Gordon . Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements. J. Clin. Gastroenterol. 2009, 43, 672.
44. Y. El Sherrif, J.R. Potts, M.R. Howard, A. Barnardo, S. Cairns, A.S. Knisely, S. Verma . Hepatotoxicity from anabolic androgenic steroids marketed as dietary supplements: Contribution from ATP8B1/ABCB11 mutations? Liver Int. 2013, 33, 1266.
45. H.L. Krüskemper . Anabolic Steroids. Academic Press: San Diego, 1968.
46. H.M. Behre, E. Nieschlag .Testosterone preparations for clinical use in males, in Testosterone: Action, Deficiency, Substitution, (Eds: E. Nieschlag, H.M. Behre, S. Nieschlag ), Springer: Berlin Heidelberg, 1998 pp. 309-335.